Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by Jefferam1on Jan 19, 2018 4:05pm
421 Views
Post# 27397328

PR anyone?

PR anyone?Do we not pay someone to do PR? 
How do I get this gig? Get some money, get some warrants. Sit on my butt and do nothing.

I try to Google "Antibe Therapeutics" I get nothing more than links to the ticker and old news like the crash in 2015. You'd think this is about the time for awareness to be raised. Shortly before results (4-8 weeks prior) I would expect PR to ramp up, this should hopefully raise awareness. Stock price would double to roughly 0.40-0.50. Then very positive news release in early March, with the added awareness of recent weeks, stock prices doubles again to 0.80-1.00 (or possibly as high as 2.00) Market settles down, 30% drop in price... Then the bidding war begins to buy out this product. Here comes 3.00-6.00 only 4-6 months away. Haha, at least that's how I dream it up in my head.

On a side note, I value your poor opinion. I mean I value your comments PoorOpinion.
Sorry I had to go for the pun.  But in all honesty I do agree it's very healthy to question penny stocks and raise potential concerns. Unfortunately most of it was over my head but I do respect people who are asking questions as you were rather than the people who simply bash. And as always I respect the response from StrikingMoose who clearly understands this stuff much better then I.
I sit on the fence weather to add or sell before the results. I'm way to heavy invested in this stock as it stands but if I double my position it may be the difference to allow me to quit a job I don't truly enjoy (but pays the bills). On the flip, if for some reasons the results are negative (not sure how that could happen), I don't want to set my Plan B retirement date any further out then it already is. lol
Bullboard Posts